Showing results (1311-1320 of 25,391) with videos related to
Sort By:
Pageof 2,540
International Journal of Cancer|October 15, 1990
Gastrin-releasing peptide in normal and neoplastic human lung: measurement and biochemical characterizationJ M McKillop, J P McCann, J R Gibbons, et al.International Journal of Cancer|July 1, 2011
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cellsTetsuhiro Chiba, Eiichiro Suzuki, Masamitsu Negishi, et al.International Journal of Cancer|July 1, 2011
Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancerYoshimi Arima, Naoki Hayashi, Hidemi Hayashi, et al.International Journal of Cancer|November 15, 1990
Diet, body mass and colorectal cancer: a case-referent study in StockholmM Gerhardsson de Verdier, U Hagman, G Steineck, et al.International Journal of Cancer|November 15, 1990
Suppressive effects of intracellular glutathione on hydroxyl radical production induced by tumor necrosis factorN Yamauchi, N Watanabe, H Kuriyama, et al.International Journal of Cancer|November 15, 1990
Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell lineH Y Zhang, K Yao, H C Zhu, et al.International Journal of Cancer|June 29, 2011
ERK2 is essential for the growth of human epithelioid malignant mesotheliomasArti Shukla, Jedd M Hillegass, Maximilian B MacPherson, et al.International Journal of Cancer|June 29, 2011
The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2)Henrik Gross, Stephanie Barth, Thorsten Pfuhl, et al.International Journal of Cancer|June 29, 2011
Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursorAnna Maria Orengo, Marina Fabbi, Loredana Miglietta, et al.International Journal of Cancer|June 29, 2011
miR 488* inhibits androgen receptor expression in prostate carcinoma cellsKavleen Sikand, Jinani E Slaibi, Rajesh Singh, et al.Pageof 2,540